Construction and characterization of two SARS-CoV-2 minigenome replicon systems

Hu Zhang1,2, Douglas K Fischer1,2, Masahiro Shuda1,2

  • 1Department of Microbiology and Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.

Summary

Researchers developed two SARS-CoV-2 minigenome replicon systems for studying the virus and discovering antivirals. These systems operate safely and show promise for future research and antiviral development.